c.okafor

TL3 Regular · Abuja, NG

Public health background. Interested in what happens to people who cannot get any of this through a clinic.

Joined 12 October 2024 · last posted 2d

146 posts, newest first. Showing up to 150.

Pooling trials with different estimands Replied, post #130 · Evidence › Meta-analyses · 26 Jul 2026 · 0 likes Adding the measurement that post #129 says would settle it. Worth separating pooling trials with different estimands as a question about the compound from pooling…
Impurity thresholds: where the common numbers come from Replied, post #13 · Analytics › Impurities & related substances · 23 Jul 2026 · 2 likes This follows post #12 rather than contradicting it. Two questions I would want answered before drawing anything from the impurity thresholds data above: how were the…
How to ask about something you suspect is a bad idea — a second dataset Replied, post #2 · marked as the solution · Start Here › How to Ask · 22 Jul 2026 · 10 likes Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box" saves three replies suggesting the diluent.
Programming during a large energy deficit Replied, post #43 · Nutrition & Training › Resistance training · 18 Jul 2026 · 6 likes Maintenance phases are where most people report training going best, which is unsurprising and is worth saying to anybody struggling during loss. That is what the…
Seven-day rolling means and why weekly readings mislead Replied, post #52 · Outcomes › Progress reports · 18 Jul 2026 · 30 likes Two claims get bundled together under seven-day rolling and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Why side effects reset at each escalation and that is not a failure Replied, post #6 · Practice › Side effects · 17 Jul 2026 · 7 likes Good question, well framed, and I would like to see it answered properly.
Why the timeline is on the right and not the left — what changed since Replied, post #72 · Meta › Site feedback · 11 Jul 2026 · 0 likes Worth separating two things that post #70 runs together. Source for the timeline figure, since it was asked for. It is in the discussion rather than the abstract, which…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #71 · Compounds › Secretagogues & GH axis · 11 Jul 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #95 · Evidence › Journal club · 10 Jul 2026 · 11 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #4 · Clinical › Comorbidities · 9 Jul 2026 · 0 likes Speaking only to Osteoarthritis and mechanical versus metabolic as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #43 · Nutrition & Training › Protein & intake · 8 Jul 2026 · 11 likes A note on how Protein density versus volume gets discussed rather than on Protein density versus volume itself: the confident posts get the replies and the careful ones…
Substitution between formats during a shortage — what changed since Replied, post #3 · marked as the solution · Access › Shortages · 7 Jul 2026 · 28 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. A weak preference…
Follow-up: Sleep quality changes during weight loss Replied, post #56 · Wellbeing › Sleep · 28 Jun 2026 · 5 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #26 · Analytics › Impurities & related substances · 26 Jun 2026 · 0 likes Scavengers and cleavage-cocktail residues can persist and appear as small early-eluting peaks. They are process-related rather than sequence-related, which is a useful…
Follow-up: External review after an internal denial Replied, post #6 · Access › Insurance & coverage · 23 Jun 2026 · 27 likes The stated reason for a denial is the generalisable part of anybody's account here. The outcome is not. That is the version I would defend. It is not the version I…
Request: a per-category review queue Replied, post #50 · Meta › Feature requests · 21 Jun 2026 · 0 likes Adding the measurement that post #47 says would settle it. Filing a mild objection to the consensus on per-category review queue. Mild because I might be wrong; an…
Spreadsheets: an appreciation — what changed since Replied, post #75 · Lounge › Off topic · 19 Jun 2026 · 17 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
An appeal that succeeded, with the letter structure — the long version Replied, post #110 · Access › Insurance & coverage · 17 Jun 2026 · 0 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #16 · Evidence › Meta-analyses · 16 Jun 2026 · 10 likes Agreed on all of that, and I have nothing to add to it.
An appeal that succeeded, with the letter structure — the long version Replied, post #75 · Access › Insurance & coverage · 9 Jun 2026 · 0 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose. I am not the right person to answer the follow-up to this.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #10 · Pharmacology › Receptor biology · 4 Jun 2026 · 1 like Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
What to include when your question involves a chromatogram — one year on Replied, post #24 · Start Here › How to Ask · 3 Jun 2026 · 2 likes I had written a reply contradicting post #22 and deleted it. Here is what survived. If the answer you got does not fit your case, say which part does not fit rather…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #18 · Practice › Storage & stability · 2 Jun 2026 · 0 likes Narrowing post #17, because the general version has more than one answer. Temperature excursions in transit are common and are not all equal. A few hours warm is a…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #48 · Wellbeing › Sleep · 1 Jun 2026 · 14 likes Energy availability affects sleep in both directions, and a large deficit can produce either fragmentation or unusual sleepiness. I have written this out at length…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #31 · Analytics › HPLC & UHPLC · 23 May 2026 · 0 likes Picking up post #30: that is the part I would want checked first. A shoulder on the trailing edge is most often a closely related species rather than an artefact. The…
Official shortage notices and what they authorise Replied, post #64 · Access › Shortages · 23 May 2026 · 17 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread.
Reading U-100 graduations, with a conversion table — what changed since Replied, post #3 · Devices › Syringes & needles · 23 May 2026 · 13 likes Reading the barrel at eye level matters more than any equipment choice. Parallax at a shallow angle is enough to shift a reading by a graduation.
What a certificate commits its issuer to — one year on Replied, post #68 · Analytics › COA interpretation · 14 May 2026 · 4 likes Worth separating two things that post #64 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #109 · Compounds › Tirzepatide · 4 May 2026 · 2 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
Preservatives: function, testing, and limits — one year on Replied, post #14 · Pharmacology › Formulation chemistry · 3 May 2026 · 1 like Adding a note of thanks rather than an opinion. I did not know most of that.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #82 · Devices › Syringes & needles · 3 May 2026 · 10 likes On post #80 — agreed on the reasoning, with one qualification. My understanding of 0.3 ml versus 0.5 ml is a few years old and may have been superseded. If it has been,…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #61 · Devices › Syringes & needles · 26 Apr 2026 · 12 likes Post #60 is the version of this I will quote in future. One addition. Practical note on 0.3 ml versus 0.5 ml: write down what you expect before you look. The number of…
Reading a home test result without over-claiming Replied, post #19 · Analytics › Home & field testing · 21 Apr 2026 · 1 like The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
Converting between mg/mL and units per dose, both directions — the long version Started this topic · Practice › Reconstitution · 16 Apr 2026 · 4 likes Converting between mg/mL and units per dose, both directions — the long version Writing it up because I had to work it out twice and would rather nobody else did.…
GLP-1 receptor distribution: central and peripheral Replied, post #31 · Pharmacology › Receptor biology · 13 Apr 2026 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #29 · Analytics › HPLC & UHPLC · 11 Apr 2026 · 0 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Method validation is the demonstration that a method can separate…
Reflux appearing for the first time at a dose step Replied, post #4 · Practice › Side effects · 11 Apr 2026 · 8 likes Adding the measurement that post #3 says would settle it. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #8 · Compounds › Oral incretins · 11 Apr 2026 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Why administration conditions matter for oral semaglutide and not for injectables: the oral…
Micro-titration: a disputed topic, argued properly Replied, post #58 · Practice › Dosing & titration · 10 Apr 2026 · 13 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
Foaming during reconstitution and whether it matters — the long version Replied, post #90 · Practice › Reconstitution · 7 Apr 2026 · 0 likes This follows post #88 rather than contradicting it. Something worth flagging about Foaming during reconstitution: the strongest-sounding claims in this thread are the…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #11 · Practice › Interactions · 16 Mar 2026 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #57 · Lounge › Introductions · 13 Mar 2026 · 1 like Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
Follow-up: Search filters: what is missing Replied, post #51 · Meta › Site feedback · 12 Mar 2026 · 17 likes Clear enough that I do not think I have a follow-up, which is unusual.
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #44 · Compounds › Cagrilintide & amylin analogues · 5 Mar 2026 · 27 likes That is a cleaner way of putting what I was circling around.
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #9 · Practice › Dosing & titration · 5 Mar 2026 · 0 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #33 · Practice › Administration · 3 Mar 2026 · 3 likes Post #30 is right about the mechanism and I think understates the practical bit. Bleeding at the injection site: normal and usually minimal. A little blood at the…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #113 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #40 · Evidence › Study critique · 9 Feb 2026 · 6 likes Hold a trial to the standard something could actually have met. A criticism that no achievable design could have answered is a criticism of the field rather than of the…
Coverage in the US: a map of the usual obstacles Replied, post #45 · Regional › North America · 2 Feb 2026 · 20 likes Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable. I would treat the…
Reading a regulatory notice rather than an article about it Started this topic · Sourcing › Regulatory · 2 Feb 2026 · 49 likes Posting this under the heading it deserves: Reading a regulatory notice rather than an article about it Everything below is what sits behind that. Posting a small…
Trifluoroacetate content and its consequences Replied, post #48 · Analytics › Impurities & related substances · 30 Jan 2026 · 0 likes Post #45 answers the question as asked. The question underneath it is different. I would be cautious about generalising from the trifluoroacetate content example above.…
Guidelines revision: what changed and why — one year on Replied, post #64 · Meta › Announcements · 29 Jan 2026 · 17 likes I read post #62 twice before replying, because I had assumed the opposite. Guidelines revision: I have looked for the primary source twice and failed twice. Either it…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #67 · Pharmacology › Pharmacokinetics · 24 Jan 2026 · 6 likes Agreed, and I will stop repeating the version of this I had been repeating.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #139 · Documentation › Doc review · 24 Jan 2026 · 4 likes An update on my earlier Promotion criteria post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #6 · Sourcing › Vendor reports · 18 Jan 2026 · 29 likes I had written a reply contradicting post #4 and deleted it. Here is what survived. Comparing your result to somebody else's on a different lot is not a comparison of…
Follow-up: Search filters: what is missing Replied, post #15 · Meta › Site feedback · 15 Jan 2026 · 8 likes For anyone finding this later: the short answer on Search filters is that it depends on one thing, and the rest of the thread is people identifying which thing.
Reading SURMOUNT-1 without the press release — one year on Replied, post #38 · Compounds › Tirzepatide · 14 Jan 2026 · 23 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #60 · Regional › UK & Ireland · 12 Jan 2026 · 0 likes The most useful reply I ever got about Private prescribing was a request to state my units. It sounds like pedantry and it has saved me twice.
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #49 · Practice › Storage & stability · 11 Jan 2026 · 28 likes This is the first time the answer has come with its own limits attached. Appreciated.
A partial dose because the pen emptied mid-injection Replied, post #93 · Practice › Administration · 10 Jan 2026 · 4 likes Research-use-only preparations are not supplied with administration instructions because they are not supplied for administration. Anything in this subcategory…
A partial dose because the pen emptied mid-injection Replied, post #78 · Practice › Administration · 9 Jan 2026 · 29 likes Post #74 put the caveat in the right place and I want to underline it. Filing a mild objection to the consensus on partial dose because the pen. Mild because I might be…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #83 · Compounds › Oral incretins · 6 Jan 2026 · 0 likes Worth separating two things that post #81 runs together. Missed doses behave differently for a daily oral than for a weekly injection. With a short interval you are…
Vomiting: when it is expected and when it is a reason to stop Replied, post #8 · Practice › Side effects · 26 Dec 2025 · 2 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #127 · Practice › Reconstitution · 25 Dec 2025 · 31 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Pre-registering a personal experiment, seriously — a second dataset Replied, post #9 · Research Methods › N-of-1 designs · 9 Dec 2025 · 11 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #25 · Devices › Pens & autoinjectors · 5 Dec 2025 · 8 likes Confirming post #23 from a second method, which matters more than confirming it from a second person. Needle installation: some pens require a fresh needle for each…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #21 · Research Methods › N-of-1 designs · 21 Nov 2025 · 0 likes Committing to post the result before you know it is a useful precommitment, and this subcategory is a reasonable place to make it.
Sleep quality changes during weight loss — what changed since Replied, post #66 · Wellbeing › Sleep · 16 Nov 2025 · 19 likes Second this, and I would have said it less carefully.
[2026 update] What steady state means for the decision to escalate Replied, post #70 · Practice › Dosing & titration · 12 Nov 2025 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
Sleep quality changes during weight loss — what changed since Replied, post #57 · Wellbeing › Sleep · 9 Nov 2025 · 19 likes This follows post #54 rather than contradicting it. Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight…
Titles that describe the question, not the situation Replied, post #143 · Start Here › How to Ask · 8 Nov 2025 · 19 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #14 · Devices › Pens & autoinjectors · 7 Nov 2025 · 5 likes This follows post #11 rather than contradicting it. Storage instructions for a pen typically differ before and after first use, and the in-use period is the one people…
Second pass at: Programming during a large energy deficit Replied, post #69 · Nutrition & Training › Resistance training · 6 Nov 2025 · 14 likes Post #68 is the version of this I will quote in future. One addition. Where the Programming during a large energy discussion usually stalls is that nobody wants to say…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #56 · Compounds › Tirzepatide · 26 Oct 2025 · 29 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #59 · Compounds › Tirzepatide · 21 Oct 2025 · 0 likes Post #57 describes the usual case. This is about the unusual one. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #33 · Practice › Interactions · 16 Oct 2025 · 4 likes Where the Warfarin and altered intake discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the…
New subcategory: rationale and scope Replied, post #21 · Meta › Announcements · 14 Oct 2025 · 0 likes Filing a mild objection to the consensus on new subcategory. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Where to report an adverse event officially, by region — a second dataset Replied, post #8 · Safety › Adverse events · 9 Oct 2025 · 0 likes On post #4 — agreed on the reasoning, with one qualification. Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #116 · Practice › Side effects · 3 Oct 2025 · 23 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
Reading SURMOUNT-1 without the press release Replied, post #22 · Compounds › Tirzepatide · 1 Oct 2025 · 19 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. A definition problem is doing most of the work in this reading SURMOUNT-1 without…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #67 · Evidence › Preprints · 1 Oct 2025 · 24 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #40 · Evidence › Journal club · 26 Sep 2025 · 24 likes Confirming post #39 from a second method, which matters more than confirming it from a second person. The baseline characteristics table is the single most useful page…
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #44 · Compounds › Repair & healing peptides · 17 Sep 2025 · 0 likes Taking post #41 at face value and following it one step further. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
Where impurities in solid-phase peptide synthesis come from Replied, post #8 · Analytics › Impurities & related substances · 17 Sep 2025 · 5 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful. Two…
Dead volume across syringe and needle combinations Replied, post #2 · Devices › Syringes & needles · 16 Sep 2025 · 0 likes Coring the stopper is a real phenomenon with repeated entries at the same point and blunt needles. Varying the entry point slightly and using a fresh needle prevents…
Payment method and the leverage it gives you, ranked Replied, post #10 · Sourcing › Payments · 14 Sep 2025 · 2 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #40 · Analytics › COA interpretation · 3 Sep 2025 · 27 likes Post #39 is the version of this I will quote in future. One addition. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail.…
Hypertension improvement and when medication needs revisiting Replied, post #33 · Clinical › Comorbidities · 30 Aug 2025 · 1 like Where I would push back on the hypertension improvement consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Preparing for an appointment: one page, three questions Replied, post #30 · Clinical › Prescriber conversations · 4 Aug 2025 · 26 likes Where I part company with post #28, and it is a narrow parting. A second opinion is a normal part of medicine rather than an accusation, and asking how to obtain one is…
Progressive overload when the scale is falling Replied, post #5 · Nutrition & Training › Resistance training · 3 Aug 2025 · 10 likes Building on post #4 rather than restating it. Two claims get bundled together under progressive overload and they need separating. The descriptive one — this is what…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #65 · Clinical › Comorbidities · 5 Jul 2025 · 0 likes The arithmetic in post #62 is right; the assumption feeding it is the part to check. A note on scope: what I am saying about Cardiovascular risk applies to the case in…
Reading a chromatogram someone posted without axes Replied, post #50 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 1 like Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
Sequence verification for an obscure compound: how it is done Replied, post #62 · Compounds › Other compounds · 14 Jun 2025 · 4 likes That is a cleaner way of putting what I was circling around.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #112 · Clinical › Comorbidities · 12 Jun 2025 · 1 like A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history. Anyone who has looked…
A newcomer's list of things that confused me, and the fixes Replied, post #12 · Start Here › Welcome · 12 Jun 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #23 · Sourcing › Regulatory · 11 Jun 2025 · 4 likes Post #20 answers the question as asked. The question underneath it is different. A regulator's public assessment report is usually the single best free source on a…
Coming back to: When "no data" is the complete and final answer Replied, post #9 · Compounds › Other compounds · 9 Jun 2025 · 11 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
[2026 update] An appeal that failed, and what I would do differently Replied, post #35 · Access › Insurance & coverage · 9 Jun 2025 · 25 likes Worth separating two things that post #31 runs together. Agreed on appeal, with one qualification that I think matters. The reasoning holds for the case as described.…
Counter-ion content and its effect on measured mass Replied, post #58 · Analytics › Mass spectrometry · 7 Jun 2025 · 9 likes Confirming post #55 from a second method, which matters more than confirming it from a second person. Quantitation by MS: most quantitation is done by LC-UV detection…
Regression to the mean in progress reports Replied, post #17 · Research Methods › Statistics · 5 Jun 2025 · 30 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #131 · Compounds › Semaglutide · 24 May 2025 · 2 likes Adding the measurement that post #128 says would settle it. Filing a mild objection to the consensus on SELECT. Mild because I might be wrong; an objection because…
Half-life, steady state, and accumulation worked through Replied, post #13 · Pharmacology › Pharmacokinetics · 23 May 2025 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
Reading a trial's population section before its results — does this still hold? Replied, post #132 · Evidence › Trials · 22 May 2025 · 10 likes Composite endpoints should be read component by component. A composite driven entirely by its softest component is a different finding from one where the components…
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #37 · Regional › UK & Ireland · 14 May 2025 · 29 likes Post #36 is right about the mechanism and I think understates the practical bit. The reason Pharmacy supply is hard to answer is that the obvious measurement and the…
TB-500 and thymosin beta-4: the fragment versus the protein Started this topic · Compounds › Repair & healing peptides · 21 Apr 2025 · 57 likes TB-500 and thymosin beta-4: the fragment versus the protein Writing it up because I had to work it out twice and would rather nobody else did. TB-500 and thymosin…
Telehealth prescribing models in the US Replied, post #86 · Regional › North America · 18 Apr 2025 · 3 likes Reading rather than answering, but this is the post I would point somebody at.
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #16 · Evidence › Journal club · 14 Apr 2025 · 1 like The arithmetic in post #14 is right; the assumption feeding it is the part to check. An hour is enough for one paper read properly and not enough for two read partly.…
A vial that will not fully dissolve: what to check and in what order Replied, post #15 · Practice › Reconstitution · 10 Apr 2025 · 1 like Worked example, since the arithmetic is the whole question. Five milligrams into one millilitre is 5 mg/mL. A 0.25 mg dose is 0.05 mL, which is five units on a U-100…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #64 · Compounds › Semaglutide · 4 Apr 2025 · 0 likes SELECT looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
UK access routes, dated and sourced — a second dataset Replied, post #52 · Regional › UK & Ireland · 19 Mar 2025 · 5 likes Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #117 · Sourcing › Vendor reports · 18 Mar 2025 · 7 likes Where you submitted more than one vial from a consignment, say so. Intra-consignment comparison is one of the more useful things an individual can contribute. The…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #78 · Sourcing › Vendor reports · 17 Mar 2025 · 31 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #40 · Devices › Syringes & needles · 11 Mar 2025 · 2 likes For anyone finding this later: the short answer on Gauge and length selection is that it depends on one thing, and the rest of the thread is people identifying which…
Scheduled maintenance and what will be unavailable Replied, post #68 · Meta › Announcements · 10 Mar 2025 · 0 likes Taking post #65 at face value and following it one step further. Scheduled maintenance has a well-known answer and a correct answer, and the interesting work is…
Journal club: SURMOUNT-1, read without the press release Replied, post #73 · Evidence › Journal club · 7 Mar 2025 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #60 · Sourcing › Regulatory · 2 Mar 2025 · 20 likes Helpful, and short, which on this subject is harder than long.
Criticising the method without criticising the authors Replied, post #43 · Evidence › Study critique · 28 Feb 2025 · 10 likes Taking criticising the method without criticising seriously for a moment rather than deflecting: the honest position is that the community has observations and no…
Adjudicated events and why the definition matters — the long version Replied, post #26 · Evidence › Trials · 27 Feb 2025 · 15 likes Post #25 is the version of this I will quote in future. One addition. On Adjudicated events the community has more anecdote than the confidence in this thread implies,…
Consistent declarations and why they matter more than clever ones Replied, post #69 · Sourcing › Logistics · 22 Feb 2025 · 14 likes I keep a log for consistent declarations specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #128 · Evidence › Journal club · 15 Feb 2025 · 17 likes I had written a reply contradicting post #124 and deleted it. Here is what survived. Reading this SURPASS-2 thread as someone who came in with a fixed view: the third…
Prior authorisation: what the criteria usually require Replied, post #5 · Access › Insurance & coverage · 11 Feb 2025 · 12 likes An honest declaration on prior authorisation: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #34 · Access › International · 8 Feb 2025 · 6 likes Worth separating Cross-border purchase within as a question about the compound from Cross-border purchase within as a question about the documentation. They get…
A supplier that answers analytical questions with restated claims Replied, post #21 · Sourcing › Red flags · 8 Feb 2025 · 0 likes Supplier sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #41 · Compounds › Secretagogues & GH axis · 4 Feb 2025 · 0 likes Post #37 and I disagree about the size of the effect, not about the direction. I think the pulsatile secretion question is answerable and has not been answered, which…
What changed in 2026, by region Replied, post #121 · Access › International · 4 Feb 2025 · 18 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #54 · Data & Tools › Calculators · 16 Jan 2025 · 22 likes Where I part company with post #50, and it is a narrow parting. Nothing a calculator produces is medical advice, and a correct calculation on inappropriate inputs is…
What changed in 2026, by region Replied, post #79 · Access › International · 15 Jan 2025 · 31 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. Speaking for myself and not for…
Recovery when intake is low: what to cut first Replied, post #89 · Nutrition & Training › Resistance training · 15 Jan 2025 · 1 like Small methodological point on recovery: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Oxidation pathways for methionine and tryptophan Replied, post #30 · Analytics › Impurities & related substances · 28 Dec 2024 · 0 likes Worth separating two things that post #28 runs together. Oxidation pathways for methionine looks different depending on whether you are reading the primary literature…
Oral semaglutide bioavailability and its variability between people — a second dataset Started this topic · Compounds › Oral incretins · 24 Dec 2024 · 13 likes Oral semaglutide bioavailability and its variability between people — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a…
Body image changing more slowly than the body Replied, post #66 · Wellbeing › Mental health · 18 Dec 2024 · 0 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. This is where my…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #16 · Clinical › Special populations · 20 Nov 2024 · 12 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit. Two people…
EMA product information as a primary source — does this still hold? Replied, post #66 · Regional › European Union · 16 Nov 2024 · 6 likes On EMA product information: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #68 · Compounds › Repair & healing peptides · 16 Nov 2024 · 0 likes That is consistent with mine, for whatever one more account is worth.
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #28 · Compounds › Semaglutide · 16 Nov 2024 · 15 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #27 · Access › Insurance & coverage · 15 Nov 2024 · 15 likes Answering the question post #25 raises rather than the one it answers. My understanding of Step therapy requirements is a few years old and may have been superseded. If…
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #7 · Practice › Dosing & titration · 11 Nov 2024 · 4 likes I had written a reply contradicting post #4 and deleted it. Here is what survived. Summarising the Holding a dose thread so far, since it is long and the answer is…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #20 · Compounds › Tirzepatide · 3 Nov 2024 · 12 likes Coming back to post #16, because the follow-up matters more than the original answer. Research-use-only tirzepatide is not approved for human use and is not made to…
What a seizure notice actually says Replied, post #4 · Sourcing › Logistics · 24 Oct 2024 · 5 likes Notice of a delay before the quoted window elapses is a materially different service experience from notice afterwards, and it is worth recording which happened. If…
Progressive overload when the scale is falling — one year on Replied, post #139 · Nutrition & Training › Resistance training · 9 Oct 2024 · 8 likes What I would want before treating Progressive overload as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Reporting a discrepancy without making an allegation Replied, post #84 · Sourcing › Vendor reports · 21 Sep 2024 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #80 · Nutrition & Training › Hydration & electrolytes · 7 Sep 2024 · 0 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
Reporting a discrepancy without making an allegation Replied, post #48 · Sourcing › Vendor reports · 29 Aug 2024 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. The general case is well…
High-resolution MS on aggregates and what it can see — one year on Replied, post #5 · Analytics › Mass spectrometry · 9 Aug 2024 · 1 like Worth separating two things that the opening post runs together. Mass error in parts per million is (observed minus theoretical) divided by theoretical, times a…
Coming back to: Pricing far outside the range, in either direction Replied, post #22 · Sourcing › Red flags · 1 Aug 2024 · 0 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. Noting that I have skin in…
Taste changes and food aversion, reported and discussed Replied, post #2 · Practice › Side effects · 11 Jul 2024 · 3 likes Worth separating two things that the opening post runs together. Practical experience of taste changes and food aversion, offered as one case with the conditions…